Merkel Cell Less Common, With Higher Mortality Than Melanoma
TOPLINE: Merkel cell carcinoma (MCC) is less common and is associated with higher mortality rates than melanoma, according to a study that also reported that male gender, older age, and …
Polyomavirus Antibody Test Predicts Merkel Cell Recurrence
Sep 10, 2025 · Rising Merkel cell polyomavirus oncoprotein antibody titers predict a 58% recurrence risk at 12 months, while falling or negative titers are associated with disease-free …
UV Radiation and MCPyV Account for Most Merkel Cell Cases
Merkel cell polyomavirus (MCPyV) and ambient ultraviolet radiation (UVR) exposure account for most Merkel cell carcinoma (MCC) cases in the United States. Researchers evaluated 38,020 …
Hepatitis D Virus Classified as Carcinogenic: Implications
Oct 3, 2025 · WHO’s classification of hepatitis D virus as carcinogenic raises urgent questions for vaccination, screening, and treatment strategies worldwide.
Merkel Cell Carcinoma: Not Just Another Skin Cancer - Medscape
Oct 27, 2017 · Merkel cell expert Paul Nghiem, MD, PhD, explains how this rare but deadly condition differs from other forms of skin cancer.
Merkel Cell Carcinoma of the Left Temple - Medscape
Merkel cell carcinoma (MCC) is at the top of this list, but other poorly differentiated small-cell tumors, including metastatic small cell carcinoma of the lung, metastatic carcinoid, lymphoma ...
Review Highlights Laser Treatment of Nonmelanoma Skin Cancer
Aug 5, 2024 · Of the 50 studies, 37 focused on lasers for the treatment of basal cell carcinoma (BCC), 10 on lasers for the treatment of squamous cell carcinoma (SCC), and three on the …
Neoadjuvant Nivolumab 'Promising' in Merkel Cell Carcinoma
May 7, 2020 · Neoadjuvant nivolumab (Opdivo, Bristol-Myers Squibb) could improve outcomes for patients with high-risk resectable Merkel cell carcinoma (MCC), say researchers reporting the …
FDA Approves Pembrolizumab for Advanced Merkel Cell …
Dec 20, 2018 · The US Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda, Merck), a programmed cell death–ligand-1 (PD-L1) inhibitor, for the treatment of …
FDA Approves New Merkel Cell Carcinoma Drug Zynyz - Medscape
Mar 22, 2023 · The PD-1 inhibitor received accelerated approval for adults with metastatic or recurrent locally advanced Merkel cell carcinoma.